MOKRÁ, Lenka, Karel HEJDUK, Zbyněk BORTLÍČEK and Renata CHLOUPKOVÁ. RENIS Afinitor – Klinický registr pacientů s renálním karcinomem: stav registru k datu 15. 9. 2015 (RENIS Afinitor – Clinical registry of patients with renal cell carcinoma: status of the registry as of 15 September 2015). Brno: Masarykova univerzita, 2015, 44 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name RENIS Afinitor – Klinický registr pacientů s renálním karcinomem: stav registru k datu 15. 9. 2015
Name (in English) RENIS Afinitor – Clinical registry of patients with renal cell carcinoma: status of the registry as of 15 September 2015
Authors MOKRÁ, Lenka (203 Czech Republic, belonging to the institution), Karel HEJDUK (203 Czech Republic, guarantor, belonging to the institution), Zbyněk BORTLÍČEK (203 Czech Republic, belonging to the institution) and Renata CHLOUPKOVÁ (203 Czech Republic, belonging to the institution).
Edition Brno, 44 pp. 2015.
Publisher Masarykova univerzita
Other information
Original language Czech
Type of outcome Research report
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/15:00086879
Organization unit Faculty of Medicine
Keywords in English renal cell carcinoma; cancer; registry; targeted therapy
Changed by Changed by: Mgr. Jakub Gregor, Ph.D., učo 16577. Changed: 2/3/2016 15:16.
Abstract
Zpráva shrnuje aktuální výsledky z registru RENIS - hodnocení účinnosti a bezpečnosti léčby metastatického renálního karcinomu přípravky cílené léčby v ČR.
Abstract (in English)
The report summarizes results of from the RENIS registry - evaluation of effectiveness and safety of the treatment of metastatic renal cell carcinoma with targeted therapy in the Czech Republic.
PrintDisplayed: 27/7/2024 18:09